| Presented by: | The Cleveland Clinic Foundation Center for Continuing Education |
| Lecturer | Leonard H. Calabrese, DO and Christopher T. Ritchlin, MD |
| Approximate duration: | 15 mins. |
| Summary points: | This CME activity describes key events involved in altered bone remodeling in ankylosing spondylitis and discusses recent clinical trial results related to the efficacy and toxicity of biologic agents for the treatment of ankylosing spondylitis. |
| Accreditation: | The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credits.
Expiration Date: August 3, 2010. |
| Other: | |